DR. MURAT OSMAN ARCASOY, MD
Osteopathic Medicine in Durham, NC
License number
North Carolina 99-01501
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
2
3912 Dumc, Durham, NC 27710
113 Glade St, Chapel Hill, NC 27516
113 Glade St, Chapel Hill, NC 27516
Phone
(919) 668-6309
(919) 681-6160 (Fax)
(919) 960-2727
(919) 681-6160 (Fax)
(919) 960-2727
Personal information
See more information about MURAT OSMAN ARCASOY at radaris.comName
Address
Phone
113 Glade St, Chapel Hill, NC 27516
113 Glade St, Chapel Hill, NC 27516
Professional information
See more information about MURAT OSMAN ARCASOY at trustoria.com
Dr. Murat O Arcasoy, Durham NC - MD (Doctor of Medicine)
Dr. Murat O Arcasoy, Durham NC - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Durham Office
2301 Erwin Rd SUITE 6TH, Durham 27705
(919) 668-4111 (Phone)
Duke Medical Center Hematology
201 Trent Dr SUITE MC3422, Durham 27710
(919) 684-5350 (Phone)
2301 Erwin Rd SUITE 6TH, Durham 27705
(919) 668-4111 (Phone)
Duke Medical Center Hematology
201 Trent Dr SUITE MC3422, Durham 27710
(919) 684-5350 (Phone)
Certifications:
Hematology, 1996, Internal Medicine, 1991, Medical Oncology, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Ege University / Medical Faculty
SUNY Hsc
Yale University School Of Medicine
Ege University / Medical Faculty
SUNY Hsc
Yale University School Of Medicine
Murat Osman Arcasoy, Durham NC
Murat Osman Arcasoy, Durham NC
Specialties:
Hematologist
Address:
Po Box 3912, Durham, NC 27710
Education:
Ege University, Faculty of Medicine - Doctor of Medicine
Yale New Haven Psychiatric Hospital - Fellowship - Oncology (Internal Medicine)
Yale New Haven Psychiatric Hospital - Fellowship - Hematology
SUNY State University Hospital of Brooklyn - Residency - Internal Medicine
Yale New Haven Psychiatric Hospital - Fellowship - Oncology (Internal Medicine)
Yale New Haven Psychiatric Hospital - Fellowship - Hematology
SUNY State University Hospital of Brooklyn - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Murat Arcasoy, Durham NC
Murat Arcasoy, Durham NC
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology, Hematology
Work:
Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
1000 Trent Dr, Durham, NC 27710
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
1000 Trent Dr, Durham, NC 27710
Education:
Ege Universitesi (1987)
Use Of Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
Use Of Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
US Patent:
8617844, Dec 31, 2013
Filed:
Aug 27, 2012
Appl. No.:
13/595436
Inventors:
Murat O. Arcasoy - Chapel Hill NC, US
Zishan A. Haroon - Ironwood MI, US
Zishan A. Haroon - Ironwood MI, US
Assignee:
Duke University - Durham NC
International Classification:
C12N 15/09, C12N 15/12, C07H 21/02, C07H 21/04
US Classification:
435 691, 536 231, 536 235
Abstract:
Nucleic acids encoding erythropoietin receptor isoforms are described, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
Use Of Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
Use Of Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
US Patent:
7598057, Oct 6, 2009
Filed:
Aug 30, 2006
Appl. No.:
11/512501
Inventors:
Murat O. Arcasoy - Chapel Hill NC, US
Zishan A. Haroon - Ironwood MI, US
Zishan A. Haroon - Ironwood MI, US
Assignee:
Duke University - Durham NC
International Classification:
C12N 15/00, C07H 21/04, C07K 14/00
US Classification:
435 691, 536 231, 536 243, 530350
Abstract:
Nucleic acids encoding erythropoietin receptor isoforms are described, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
Use Of Novel Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
Use Of Novel Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
US Patent:
2010009, Apr 15, 2010
Filed:
Aug 17, 2009
Appl. No.:
12/542229
Inventors:
Murat O. Arcasoy - Chapel Hill NC, US
Zishan A. Haroon - Ironwood MI, US
Zishan A. Haroon - Ironwood MI, US
International Classification:
C12Q 1/68, C07H 21/00, C12N 15/74, C12N 5/071, C07K 14/00, C07K 16/00, C07H 21/04, G01N 33/53
US Classification:
435 6, 536 235, 4353201, 435325, 530350, 5303871, 536 2431, 435 721, 435 79
Abstract:
Nucleic acids encoding erythropoietin isoforms are described herein, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
Use Of Novel Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
Use Of Novel Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
US Patent:
2004019, Oct 7, 2004
Filed:
Jul 23, 2003
Appl. No.:
10/625137
Inventors:
Murat Arcasoy - Chapel Hill NC, US
Zishan Haroon - Ironwood MI, US
Zishan Haroon - Ironwood MI, US
International Classification:
C07K014/505, C07H021/04
US Classification:
435/069400, 435/320100, 435/325000, 530/399000, 536/023500
Abstract:
Nucleic acids encoding erythropoietin isoforms are described herein, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.
Use Of Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
Use Of Cytokine Receptors As Biomarkers And Therapeutic Targets In Human Cancer
US Patent:
8273551, Sep 25, 2012
Filed:
Jun 27, 2011
Appl. No.:
13/169641
Inventors:
Murat O. Arcasoy - Chapel Hill NC, US
Zishan A. Haroon - Ironwood MI, US
Zishan A. Haroon - Ironwood MI, US
Assignee:
Duke University - Durham NC
International Classification:
C12N 15/00, C07H 21/04, C07K 14/00
US Classification:
435 691, 536 235, 530350
Abstract:
Nucleic acids encoding erythropoietin receptor isoforms are described, as well as the encoded isoforms, methods of detecting the same, and methods of screening for and treating cancer.